日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial

新辅助帕博西尼联合阿那曲唑治疗内分泌耐药的雌激素受体阳性/HER2阴性乳腺癌疗效的生物标志物:一项II期试验

Kong, Tim; Mabry, Alex; Highkin, Maureen; Wang, Anthony Z; Hoog, Jeremy; Guo, Zhanfang; Gonzales-Gonzales, Adrian; Thomas, Shana; Song, Yingduo; Gao, Feng; Opyrchal, Mateusz; Peterson, Lindsay; Ademuyiwa, Foluso; Margenthaler, Julie; Aft, Rebecca; Glover-Collins, Katherine; Nehring, Leslie; Tao, Yu; Sanati, Souzan; Hagemann, Ian S; Boulos, Fouad; Holt, Matthew; Ding, Li; Zhu, Wenge; Oh, Stephen T; Wang, Jianxin; Witkiewicz, Agnieszka K; Knudsen, Erik S; Bose, Ron; Weber, Jason D; Goetz, Matthew; Northfelt, Donald; Luo, Jingqin; Ma, Cynthia X

Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors

真实世界中,接受细胞周期蛋白依赖性激酶 4/6 抑制剂治疗的高危和转移性激素受体阳性、人表皮生长因子受体 2 阴性乳腺癌患者的血浆胸苷激酶活性

O'Connor, Thomas N; Schultz, Emily; Kabraji, Sheheryar; Levine, Ellis; Williams, Amy J; Knudsen, Erik S; Witkiewicz, Agnieszka K

TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab

TP53 突变与接受西妥昔单抗和帕博利珠单抗治疗的晚期 RAS 野生型结直肠腺癌患者的疾病控制改善相关

Fountzilas, Christos; Rosario, Spencer; Witkiewicz, Agnieszka K; Withers, Henry G; Bajor, David L; Mukherjee, Sarbajit; Saltzman, Joel; Maguire, Orla; Minderman, Hans; Chatley, Sarah; Tarquini, Mary Lynn; Whitworth, Amy; Jurcevic, Jennifer; Hsiao, Hua-Hsin; Knudsen, Erik S; Muhitch, Jason B; Abrams, Scott I; Kalinski, Pawel; Segal, Brahm H; Bakin, Andrei; Yuan, Guangwei; Wang, Chong; Attwood, Kristopher; Iyer, Renuka; Boland, Patrick M

Differences in concentration of neuron-specific enolase (NSE), neutrophil elastase (NE), and calcium-binding protein S100B in viral diseases: a pilot study focused on normoglycemic COVID-19 patients

病毒性疾病中神经元特异性烯醇化酶 (NSE)、中性粒细胞弹性蛋白酶 (NE) 和钙结合蛋白 S100B 浓度的差异:一项针对血糖正常的 COVID-19 患者的初步研究

Adamiec-Mroczek, Joanna; Bronowicka-Szydełko, Agnieszka; Lewandowski, Łukasz; Nowak, Beata; Turno-Kręcicka, Anna; Misiuk-Hojło, Marta; Stanek, Marta; Matera-Witkiewicz, Agnieszka; Krupińska, Magdalena; Gostomska-Pampuch, Kinga; Kuźnik, Edwin; Rabczyński, Maciej; Matusiewicz, Małgorzata; Berdowska, Izabela; Korbecka, Martyna; Mykhailova, Daria; Przystupa, Zuzanna; Smyk, Beata; Wojakowska, Anna; Amedei, Amedeo; Trocha, Małgorzata; Madziarska, Katarzyna

(1)H NMR-Based Metabolomics in Pediatric Acute Lymphoblastic Leukemia: A Pilot Study of Plasma and Cerebrospinal Fluid Profiles

(1)基于核磁共振氢谱的代谢组学在儿童急性淋巴细胞白血病中的应用:血浆和脑脊液特征的初步研究

Serrafi, Agata; Pupek, Małgorzata; Lewandowski, Łukasz; Janicka-Kłos, Anna; Wasilewski, Andrzej; Kasprzak, Adrian; Matera-Witkiewicz, Agnieszka; Zatoński, Tomasz; Połtyn-Zaradna, Katarzyna; Ściskalska, Milena; Brutkowski, Tomasz; Kazanowska, Bernarda

Prevalence of hearing loss and tinnitus among school-age children: a cross-sectional analysis of the PICTURE cohort study

学龄儿童听力损失和耳鸣的患病率:PICTURE队列研究的横断面分析

Piotrowski, Jan; Pazdro-Zastawny, Katarzyna; Połtyn-Zaradna, Katarzyna; Kujawa, Krzysztof; Zatońska, Katarzyna; Matera-Witkiewicz, Agnieszka; Kiliś-Pstrusińska, Katarzyna; Zatoński, Tomasz

Targeting Distinct Cell Cycle Nodes Overcomes KRAS/RAS Inhibitor Resistance

靶向特定细胞周期节点可克服KRAS/RAS抑制剂耐药性。

Kumarasamy, Vishnu; Wang, Jianxin; Yau, Edwin; Abel, Ethan V; Witkiewicz, Agnieszka K; Knudsen, Erik S

Acquired resistance in cancer: towards targeted therapeutic strategies

癌症获得性耐药:迈向靶向治疗策略

Soragni, Alice; Knudsen, Erik S; O'Connor, Thomas N; Tognon, Cristina E; Tyner, Jeffrey W; Gini, Beatrice; Kim, Donghwa; Bivona, Trever G; Zang, Xingxing; Witkiewicz, Agnieszka K; Goodrich, David W; Jiang, Dadi; Gammon, Seth T; Willey, Christopher D; Boutros, Paul C; Sandulache, Vlad C; Osman, Abdullah A; Myers, Jeffrey N; Mehla, Kamiya; Singh, Pankaj K; Chan, Keith S; Gao, Hongbo; Marathe, Himangi

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma.

靶向 FGFR4 可消除 HNF1A 驱动的胰腺导管腺癌转移

Crawford Katherine J, Humphrey Kennedy S, Cortes Eduardo, Wang Jianxin, Kumarasamy Vishnu, Wan Yin, Long Mark D, Feigin Michael E, Witkiewicz Agnieszka K, Mann Karen M, Knudsen Erik S, Abel Ethan V

Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222.

肿瘤抑制因子对选择性 CDK2 抑制剂 BLU-222 的反应存在差异

Dommer Adam P, Kumarasamy Vishnu, Wang Jianxin, O'Connor Thomas N, Roti Michelle, Mahan Sidney, McLean Karen, Knudsen Erik S, Witkiewicz Agnieszka K